{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T11:03:06Z","timestamp":1771844586620,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,3,15]],"date-time":"2012-03-15T00:00:00Z","timestamp":1331769600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2431-12-29","type":"journal-article","created":{"date-parts":[[2012,3,15]],"date-time":"2012-03-15T22:21:33Z","timestamp":1331850093000},"source":"Crossref","is-referenced-by-count":23,"title":["Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis"],"prefix":"10.1186","volume":"12","author":[{"given":"Alex R","family":"Kemper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather A","family":"Van Mater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remy R","family":"Coeytaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"John W","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian D","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,15]]},"reference":[{"key":"563_CR1","unstructured":"Kemper AR, Coeytaux R, Sanders GD, Van Mater H, Williams JW, Gray RN, et al: Disease-Modifying Antirheumatic Drugs (DMARDs) in Children with Juvenile Idiopathic Arthritis (JIA). Comparative Effectiveness Review No. 28. (Prepared by the Duke Evidence-based Practice Center under Contract No. HHSA 290 2007 10066.) Rockville, MD: Agency for Healthcare Research and Quality. [\n                    http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK65169\/pdf\/TOC.pdf\n                    \n                  ]"},{"key":"563_CR2","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1542\/pir.27-4-e24","volume":"27","author":"EA Goldmuntz","year":"2006","unstructured":"Goldmuntz EA, White PH, Goldmuntz EA, White PH: Juvenile idiopathic arthritis: a review for the pediatrician. Pediatr Rev. 2006, 27: e24-e32. 10.1542\/pir.27-4-e24.","journal-title":"Pediatr Rev"},{"key":"563_CR3","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","volume":"40","author":"EH Giannini","year":"1997","unstructured":"Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A: Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997, 40: 1202-1209.","journal-title":"Arthritis Rheum"},{"key":"563_CR4","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/art.1780371209","volume":"37","author":"G Singh","year":"1994","unstructured":"Singh G, Athreya BH, Fries JF, Goldsmith DP: Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1994, 37: 1761-1769. 10.1002\/art.1780371209.","journal-title":"Arthritis Rheum"},{"key":"563_CR5","unstructured":"Agency for Healthcare Research and Quality: Methods Reference Guide for Effectiveness and Comparative Effectiveness Reviews, Version 1.0 [Draft posted Oct. 2007]. Rockville, MD: Agency for Healthcare Research and Quality, [\n                    http:\/\/effectivehealthcare.ahrq.gov\/repFiles\/2007_10DraftMethodsGuide.pdf\n                    \n                  ]"},{"key":"563_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","volume":"372","author":"N Ruperto","year":"2008","unstructured":"Ruperto N, Lovell DJ, Quartier P, Paz E, Rubio-Perez N, Silva CA, et al: Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet. 2008, 372: 383-391. 10.1016\/S0140-6736(08)60998-8.","journal-title":"Lancet"},{"key":"563_CR7","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa0706290","volume":"359","author":"DJ Lovell","year":"2008","unstructured":"Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K, et al: Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med. 2008, 359: 810-820. 10.1056\/NEJMoa0706290.","journal-title":"N Engl J Med"},{"key":"563_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10067-008-0995-9","volume":"28","author":"N Ilowite","year":"2009","unstructured":"Ilowite N, Porras O, Reiff A, Rudge S, Punaro M, Martin A, et al: Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study. Clin Rheumatol. 2009, 28: 129-137. 10.1007\/s10067-008-0995-9.","journal-title":"Clin Rheumatol"},{"key":"563_CR9","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1056\/NEJM200003163421103","volume":"342","author":"DJ Lovell","year":"2000","unstructured":"Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al: Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med. 2000, 342: 763-769. 10.1056\/NEJM200003163421103.","journal-title":"N Engl J Med"},{"key":"563_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/art.20904","volume":"53","author":"JA Smith","year":"2005","unstructured":"Smith JA, Thompson DJ, Whitcup SM, Suhler E, Clarke G, Smith S, et al: A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum. 2005, 53: 18-23. 10.1002\/art.20904.","journal-title":"Arthritis Rheum"},{"key":"563_CR11","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1002\/art.22838","volume":"56","author":"N Ruperto","year":"2007","unstructured":"Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, et al: A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum. 2007, 56: 3096-3106. 10.1002\/art.22838.","journal-title":"Arthritis Rheum"},{"key":"563_CR12","first-page":"919","volume":"23","author":"EH Giannini","year":"1996","unstructured":"Giannini EH, Lovell DJ, Silverman ED, Sundel RP, Tague BL, Ruperto N: Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I\/II study. J Rheumatol. 1996, 23: 919-924.","journal-title":"J Rheumatol"},{"key":"563_CR13","first-page":"117","volume":"40","author":"J Oppermann","year":"1994","unstructured":"Oppermann J, Mobius D: Therapeutical and immunological effects of methylprednisolone pulse therapy in comparison with intravenous immunoglobulin. Treatment in patients with juvenile chronic arthritis. Acta Univ Carol Med (Praha). 1994, 40: 117-121.","journal-title":"Acta Univ Carol Med (Praha)"},{"key":"563_CR14","first-page":"2353","volume":"21","author":"ED Silverman","year":"1994","unstructured":"Silverman ED, Cawkwell GD, Lovell DJ, Laxer RM, Lehman TJ, Passo MH, et al: Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. J Rheumatol. 1994, 21: 2353-2358.","journal-title":"J Rheumatol"},{"key":"563_CR15","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","volume":"371","author":"S Yokota","year":"2008","unstructured":"Yokota S, Imagawa T, Mori M, Miyamae T, Aihara Y, Takei S, et al: Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet. 2008, 371: 998-1006. 10.1016\/S0140-6736(08)60454-7.","journal-title":"Lancet"},{"key":"563_CR16","first-page":"118","volume":"13","author":"TK Kvien","year":"1986","unstructured":"Kvien TK, Hoyeraal HM, Sandstad B: Azathioprine versus placebo in patients with juvenile rheumatoid arthritis: a single center double blind comparative study. J Rheumatol. 1986, 13: 118-123.","journal-title":"J Rheumatol"},{"key":"563_CR17","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1056\/NEJM198605153142001","volume":"314","author":"EJ Brewer","year":"1986","unstructured":"Brewer EJ, Giannini EH, Kuzmina N, Alekseev L: Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial. N Engl J Med. 1986, 314: 1269-1276. 10.1056\/NEJM198605153142001.","journal-title":"N Engl J Med"},{"key":"563_CR18","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/art.1780311006","volume":"31","author":"C van Kerckhove","year":"1988","unstructured":"van Kerckhove C, Giannini EH, Lovell DJ: Temporal patterns of response to D-penicillamine, hydroxychloroquine, and placebo in juvenile rheumatoid arthritis patients. Arthritis Rheum. 1988, 31: 1252-1258. 10.1002\/art.1780311006.","journal-title":"Arthritis Rheum"},{"key":"563_CR19","first-page":"533","volume":"12","author":"TK Kvien","year":"1985","unstructured":"Kvien TK, Hoyeraal HM, Sandstad B: Slow acting antirheumatic drugs in patients with juvenile rheumatoid arthritis-evaluated in a randomized, parallel 50-week clinical trial. J Rheumatol. 1985, 12: 533-539.","journal-title":"J Rheumatol"},{"key":"563_CR20","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","volume":"326","author":"EH Giannini","year":"1992","unstructured":"Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, Vorontsov I, et al: Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. N Engl J Med. 1992, 326: 1043-1049. 10.1056\/NEJM199204163261602.","journal-title":"N Engl J Med"},{"key":"563_CR21","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F","volume":"43","author":"P Woo","year":"2000","unstructured":"Woo P, Southwood TR, Prieur AM, Dore CJ, Grainger J, David J, et al: Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum. 2000, 43: 1849-1857. 10.1002\/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F.","journal-title":"Arthritis Rheum"},{"key":"563_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/jpepsy\/jsj014","volume":"31","author":"R Riddle","year":"2006","unstructured":"Riddle R, Ryser CN, Morton AA, Sampson JD, Browne RH, Punaro MG, et al: The impact on health-related quality of life from non-steroidal anti-inflammatory drugs, methotrexate, or steroids in treatment for juvenile idiopathic arthritis. J Pediatr Psychol. 2006, 31: 262-271.","journal-title":"J Pediatr Psychol"},{"key":"563_CR23","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/art.1780280404","volume":"28","author":"AM Prieur","year":"1985","unstructured":"Prieur AM, Piussan C, Manigne P, Bordigoni P, Griscelli C: Evaluation of D-penicillamine in juvenile chronic arthritis. A double-blind, multicenter study. Arthritis Rheum. 1985, 28: 376-382. 10.1002\/art.1780280404.","journal-title":"Arthritis Rheum"},{"key":"563_CR24","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/1529-0131(199805)41:5<808::AID-ART6>3.0.CO;2-T","volume":"41","author":"MA van Rossum","year":"1998","unstructured":"van Rossum MA, Fiselier TJ, Franssen MJ, Zwinderman AH, ten Cate R, van Suijlekom-Smit LW, et al: Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Arthritis Rheum. 1998, 41: 808-816. 10.1002\/1529-0131(199805)41:5<808::AID-ART6>3.0.CO;2-T.","journal-title":"Arthritis Rheum"},{"key":"563_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/ard.62.3.245","volume":"62","author":"P Lahdenne","year":"2003","unstructured":"Lahdenne P, Vahasalo P, Honkanen V: Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study. Ann Rheum Dis. 2003, 62: 245-247. 10.1136\/ard.62.3.245.","journal-title":"Ann Rheum Dis"},{"key":"563_CR26","first-page":"80","volume":"37","author":"J Hoza","year":"1991","unstructured":"Hoza J, Kadlecova T, Nemcova D, Havelka S: Sulphasalazine and Delagil-a comparative study in patients with juvenile chronic arthritis. Acta Univ Carol Med (Praha). 1991, 37: 80-83.","journal-title":"Acta Univ Carol Med (Praha)"},{"key":"563_CR27","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMoa041810","volume":"352","author":"E Silverman","year":"2005","unstructured":"Silverman E, Mouy R, Spiegel L, Jung LK, Saurenmann RK, Lahdenne P, et al: Leflunomide or methotrexate for juvenile rheumatoid arthritis. N Engl J Med. 2005, 352: 1655-1666. 10.1056\/NEJMoa041810.","journal-title":"N Engl J Med"},{"key":"563_CR28","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1136\/ard.2003.014886","volume":"63","author":"G Horneff","year":"2004","unstructured":"Horneff G, Schmeling H, Biedermann T, Foeldvari I, Ganser G, Girschick HJ, et al: The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis. 2004, 63: 1638-1644. 10.1136\/ard.2003.014886.","journal-title":"Ann Rheum Dis"},{"key":"563_CR29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1136\/ard.2007.087593","volume":"68","author":"G Horneff","year":"2009","unstructured":"Horneff G, De Bock F, Foeldvari I, Girschick HJ, Michels H, Moebius D, et al: Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry. Ann Rheum Dis. 2009, 68: 519-525. 10.1136\/ard.2007.087593.","journal-title":"Ann Rheum Dis"},{"key":"563_CR30","first-page":"1680","volume":"35","author":"C Yildirim-Toruner","year":"2008","unstructured":"Yildirim-Toruner C, Kimura Y, Rabinovich E: Hodgkin's lymphoma and tumor necrosis factor inhibitors in juvenile idiopathic arthritis. J Rheumatol. 2008, 35: 1680-1681.","journal-title":"J Rheumatol"},{"key":"563_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/adc.86.1.47","volume":"86","author":"AG Cleary","year":"2002","unstructured":"Cleary AG, McDowell H, Sills JA: Polyarticular juvenile idiopathic arthritis treated with methotrexate complicated by the development of non-Hodgkin's lymphoma. Arch Dis Child. 2002, 86: 47-49. 10.1136\/adc.86.1.47.","journal-title":"Arch Dis Child"},{"key":"563_CR32","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1097\/01.mph.0000212960.66221.e7","volume":"28","author":"J Takeyama","year":"2006","unstructured":"Takeyama J, Sato A, Nakano K, Abukawa D, Ichinohazama R, Imaizumi M: Epstein-Barr virus associated Hodgkin lymphoma in a 9-year-old girl receiving long-term methotrexate therapy for juvenile idiopathic arthritis. J Pediatr Hematol Oncol. 2006, 28: 622-624. 10.1097\/01.mph.0000212960.66221.e7.","journal-title":"J Pediatr Hematol Oncol"},{"key":"563_CR33","first-page":"2035","volume":"24","author":"S Padeh","year":"1997","unstructured":"Padeh S, Sharon N, Schiby G, Rechavi G, Passwell JH: Hodgkin's lymphoma in systemic onset juvenile rheumatoid arthritis after treatment with low dose methotrexate. J Rheumatol. 1997, 24: 2035-2037.","journal-title":"J Rheumatol"},{"key":"563_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0046-8177(00)80230-0","volume":"31","author":"J Krugmann","year":"2000","unstructured":"Krugmann J, Sailer-Hock M, Muller T, Gruber J, Allerberger F, Offner FA: Epstein-Barr virus-associated Hodgkin's lymphoma and legionella pneumophila infection complicating treatment of juvenile rheumatoid arthritis with methotrexate and cyclosporine A. Hum Pathol. 2000, 31: 253-255. 10.1016\/S0046-8177(00)80230-0.","journal-title":"Hum Pathol"},{"key":"563_CR35","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/acr.20128","volume":"6","author":"MY Smith","year":"2010","unstructured":"Smith MY, Sobel RE, Wallace CA: Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: time for a consolidated patient registry. Arthritis Care Res. 2010, 6: 800-804.","journal-title":"Arthritis Care Res"},{"key":"563_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1546-0096-8-18","volume":"8","author":"P McCroskery","year":"2010","unstructured":"McCroskery P, Wallace CA, Lovell DJ, Stryker S, Chernyukhin N, Blosch C, Zack DJ: Summary of worldwide pediatric malignancies reported after exposure to etanercept. Pediatr Rheum. 2010, 8: 18-10.1186\/1546-0096-8-18.","journal-title":"Pediatr Rheum"},{"key":"563_CR37","unstructured":"Effective Health Care Program: Medicines for juvenile idiopathic arthritis: a review of the research for parents and caregivers. [\n                    http:\/\/www.effectivehealthcare.ahrq.gov\/index.cfm\/search-for-guides-reviews-and-reports\/?productid=753&pageaction=displayproduct\n                    \n                  ]"},{"key":"563_CR38","unstructured":"Effective Health Care Program: Effectiveness of disease-modifying antirheumatic drugs in children with juvenile idiopathic arthritis. [\n                    http:\/\/www.effectivehealthcare.ahrq.gov\/index.cfm\/search-for-guides-reviews-and-reports\/?pageaction=displayproduct&productID=754\n                    \n                  ]"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2431-12-29\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-12-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-12-29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-12-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T17:34:36Z","timestamp":1581960876000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/1471-2431-12-29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,15]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["563"],"URL":"https:\/\/doi.org\/10.1186\/1471-2431-12-29","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,15]]},"article-number":"29"}}